Thane: A senior health official on Sunday said the man from Maharashtra’s Thane district, who had tested positive for the Covid-19 Omicron variant, is in a “stable” condition and “responding well” to treatment.


“He is stable and responding well to treatment,” PTI quoted Mumbai Circle Health Services Deputy Director Dr Gauri Rathod as saying.


Dr Rathod said the man will undergo the treatment protocol, as prescribed for the Covid Omicron variant, for 14 days.


The 33-year-old marine engineer is currently undergoing treatment at a Covid care centre in Kalyan town, around 50 km from Maharashtra capital Mumbai.


Dr Rathod said the patient will continue to be treated at the Covid-19 care centre in Kalyan and will not be shifted elsewhere.


The man had arrived in Delhi on November 24 via Cape Town and had given his samples for Covid-19 testing at the Delhi airport. He had then taken a flight to Mumbai, official sources told PTI earlier in Delhi.


Meanwhile, Kalyan Dombivli Municipal Corporation’s epidemic cell chief Dr Pratibha Panpatil said that six others, who had travelled from different nations to the Kalyan-Dombivli area, have been kept in isolation after they tested Covid positive.


Dr Panpatil said the samples of these six people have been sent for genome sequencing, adding the results will be known in the coming days.


“The condition of all the six is stable. They are asymptomatic and none of them had come from high-risk countries,” she said.


Of the six people, four had travelled from Nigeria, while one each from Russia and Nepal.


Earlier in the day, India reported its fifth case of the Omicron variant from Delhi.


The country had detected its first two cases of the Omicron variant from Karnataka earlier this week, while the third and fourth cases were reported from Gujarat’s Jamnagar and Mumbai respectively.


The Centre has designated 11 countries, including South Africa, Brazil, Zimbabwe, China, Botswana, Zealand, Israel, Mauritius, Hong Kong, the United Kingdom and Singapore, as ‘at risk’ nations.